Cepheid appoints Daskal new executive vice president
with responsibilities including worldwide financial operations, information technology and investor relations management.
Cepheid specializes in molecular diagnostics and aims to provide technology in order to make the process of diagnosis easier and quicker. Their flagship system is the GeneXpert. With Daskal on board, the company hopes to invest in platform extensions and other areas to drive revenue growth.
"As we continue to extend our revenue opportunities and deliver industry-leading growth, I am confident that Ilan has the right experience and skill-set to drive our profitability objectives, and to continue to evolve our finance organization to prepare Cepheid for its future as a multi-national, billion dollar revenue business," Cepeid chairman and CEO John Bishop said. "I am very pleased to welcome a finance executive of Ilan's caliber to the Cepheid team."
Daskal has served over 20 years in finance-related positions. His most recent was as executive vice president and chief financial officer at International Rectifier Corp. He holds a bachelor's degree from the Tel-Aviv College of Management in Israel and a master's degree in finance from City University of New York.